amiodarone has been researched along with Coronary Disease in 189 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the AFIST III (Atrial Fibrillation Suppressions Trial III), anterior fat pad (AFP) retention did not decrease the incidence of postoperative atrial fibrillation (POAF), but prophylaxis with amiodarone did." | 9.13 | Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III). ( Coleman, CI; Dale, K; Gallagher, R; Henyan, N; Kluger, J; Reinhart, K; Sander, S; White, CM, 2008) |
| "Routine use of postoperative prophylactic intravenous bolus and subsequent 5 days of oral amiodarone therapy after coronary artery bypass grafting reduces the risk of atrial fibrillation and decreases the total costs of care by 175 euros per patient." | 9.13 | Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. ( Christensen, TD; Hjortdal, VE; Kristiansen, IS; Zebis, LR, 2008) |
| "The effects of a 6-week treatment with amiodarone on the P-wave triggered signal-averaged electrocardiogram in patients with paroxysmal atrial fibrillation and coronary artery disease have been studied." | 9.09 | Effects of amiodarone on the P-wave triggered signal-averaged electrocardiogram in patients with paroxysmal atrial fibrillation and coronary artery disease. ( Adamus, J; Anker, SD; Banasiak, W; Coats, AJ; Fuglewicz, A; Kalka, D; Molenda, W; Ponikowski, P; Reczuch, K; Telichowski, A, 1999) |
| "Various regimens have been proposed for the prevention of postoperative atrial fibrillation, including the use of intravenous and oral amiodarone." | 9.09 | Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery. ( Babić, R; Bojić, M; Borzanović, M; Bosković, SD; Jovanović, T; Kovacević, S; Maras, D; Marinković, J; Nastasić, S; Nesković, AN; Otasević, P; Popović, AD; Popović, Z; Vuk, L, 2001) |
| "Both amiodarone and beta-blockers have been shown to decrease the incidence of atrial fibrillation after cardiovascular surgery." | 9.09 | Amiodarone versus a beta-blocker to prevent atrial fibrillation after cardiovascular surgery. ( Greenberg, MD; Katz, NM; Kilborn, MJ; Solomon, AJ, 2001) |
| "The safety and efficacy of amiodarone and propafenone in converting atrial fibrillation or flutter after cardiac surgery were compared in a randomized double-blind trial." | 9.08 | Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. ( Cappiello, E; Di Biasi, P; Mangini, A; Paje, A; Santoli, C; Scrofani, R, 1995) |
| "We examined the chronic electrophysiologic, systemic, and pharmacologic effects of chronic oral amiodarone therapy in 24 patients with refractory ventricular tachycardia and organic heart disease." | 9.05 | Chronic effects of amiodarone in patients with refractory ventricular tachycardia. ( Cappello, G; Rothbart, ST; Saksena, S, 1983) |
| "This study aimed to assess safety and cardiovascular outcomes of dronedarone in patients with paroxysmal or persistent atrial fibrillation (AF) with coronary heart disease (CHD)." | 7.80 | Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial. ( Connolly, SJ; Crijns, HJ; Hohnloser, SH; Naditch-Brûlé, L; Page, RL; Pisters, R; Torp-Pedersen, C, 2014) |
| "The authors describe a case of a 74-year-old man with advanced coronary heart disease in whom pulmonary hemorrhagic complications during therapy with ticlopidine and subsequently with clopidogrel and amiodarone were observed." | 7.73 | [Recurrent hemoptysis following thienopyridines and amiodarone administration. therapeutic dilemma]. ( Cofta, S; Elikowski, W; Mańczak, J; Nowicki, A; Psuja, P, 2005) |
| ") administered amiodarone using four canine ventricular arrhythmia models." | 7.69 | Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia. ( Awaji, T; Hashimoto, K; Wu, ZJ, 1995) |
| "We undertook this study to determine if the cycle-length response of ventricular tachycardia (VT) to procainamide and amiodarone is similar in the individual patient." | 7.68 | Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone. ( Buxton, AE; Josephson, ME; Marchlinski, FE; Vaitkus, PT, 1990) |
| "A group of 34 consecutive patients with coronary artery disease (n = 29) or dilated cardiomyopathy (n = 5) (3 women, 31 men, age 38-80 yr) who had severely impaired left ventricular function (left ventricular ejection fraction less than or equal to 40%) and high-grade ventricular ectopic activity (sustained or nonsustained ventricular tachycardia or ventricular fibrillation) were treated with amiodarone (mean dose: 206 mg/d) and followed for 1-117 (mean: 49) months." | 7.68 | Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction. ( Burckhardt, D; Hoffmann, A; Pfisterer, M; Robertson, A, 1991) |
| "The effect of intravenous (IV) amiodarone (300 mg) on heart rate was investigated in 22 patients with acute myocardial infarction (18) or ischemia (4) and sinus tachycardia." | 7.67 | The effect of intravenous amiodarone on heart rate in patients with acute myocardial infarction or ischemia and sinus tachycardia. ( Agmon, J; Klainman, E; Kusniec, J; Sclarovsky, S; Strasberg, B, 1988) |
| "The value of serial electropharmacologic testing during long-term oral amiodarone therapy for prediction of long-term drug efficacy as well as characteristics of arrhythmia recurrence is controversial." | 7.67 | Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease. ( DiMarco, JP; Haines, DE; Lerman, BB; Zhu, J, 1987) |
| "The main goal of this project was to study the effect of amiodarone upon ventricular fibrillation and defibrillation thresholds (VFT and VDT) in the canine heart under normal and ischemic conditions." | 7.67 | Effect of amiodarone on ventricular fibrillation and defibrillation thresholds in the canine heart under normal and ischemic conditions. ( Arredondo, MT; Guillen, SG; Quinteiro, RA, 1986) |
| "Over a 10-year period 130 patients with drug-resistant cardiac arrhythmias associated mainly with coronary artery disease and its complications were treated with amiodarone." | 7.67 | Amiodarone for refractory cardiac arrhythmias: 10-year study. ( Eydt, JN; Leak, D, 1986) |
| "The prognostic importance of electrophysiologic studies in patients with sustained ventricular tachyarrhythmias treated with amiodarone was prospectively studied in 100 consecutive patients." | 7.67 | Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. ( Greenspan, AM; Horowitz, LN; Kay, HR; Morganroth, J; Rae, AP; Rotmensch, H; Segal, BL; Sokoloff, NM; Spielman, SR; Webb, CR, 1985) |
| "The values of two Holter ambulatory electrocardiographic monitoring criteria and one programmed stimulation efficacy criterion reported to be predictive of the efficacy of amiodarone were compared in 70 patients taking amiodarone for sustained ventricular tachyarrhythmias." | 7.67 | Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia. ( Felder, SD; Figura, I; Fisher, JD; Johnston, DR; Kim, SG; Waspe, LE, 1987) |
| "Amiodarone was administered orally to 30 patients with chronic stable coronary artery disease and severe ventricular arrhythmias." | 7.67 | Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease. ( Elizari, MV; Girotti, LA; Goldbarg, A; Kaski, JC; Lázzari, JO; Rosenbaum, MB; Tambussi, A, 1984) |
| "Induction of ventricular tachycardia (VT) at electrophysiologic study in patients taking amiodarone poorly predicts recurrence of VT." | 7.67 | Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrop ( Chang, MS; Fineberg, N; Heger, JJ; Kammerling, JM; Klein, LS; Miles, WM; Prystowsky, EN; Zipes, DP, 1988) |
| "A case of pulmonary fibrosis attributed to amiodarone was studied immunologically and morphologically." | 7.67 | Amiodarone-associated pulmonary fibrosis. Evidence of an immunologically mediated mechanism. ( Bell, R; Eudy, S; Fan, K; Fullenwider, J, 1987) |
| " The aim of our study was to evaluate the effects of amiodarone (400 mg day-1 for seven days and then 200 mg day-1, five days a week, for 60 days) in 20 patients with chronic ischaemic heart disease ascertained by stress test, thallium-201 myocardial scintigraphy and coronary angiography and with qualitatively and quantitatively similar cardiac arrhythmias in two continuous ECG monitoring sessions performed before starting treatment." | 7.67 | Effects of low doses of amiodarone on cardiac arrhythmias in patients with chronic ischaemic heart disease. ( Abrignani, MG; Alaimo, G; Cutietta, A; Immordino, R; Indovina, A; Licata, G; Novo, S; Strano, A, 1988) |
| "Amiodarone was used in 86 patients with ventricular tachycardia (VT) (67 patients) or ventricular fibrillation (19 patients) secondary to coronary artery disease." | 7.67 | Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone. ( Estes, NA; Manolis, AS; Uricchio, F, 1989) |
| "The effects of amiodarone and its metabolite desethylamiodarone on arrhythmias induced by ischaemia and reperfusion were studied in vivo in the anaesthetised rat with transient regional ischaemia (7 min of left coronary artery occlusion) and reperfusion (10 min)." | 7.67 | Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat. ( Hearse, DJ; Riva, E, 1989) |
| "Six patients are presented who developed pulmonary infiltrates of undetermined origin while being treated for severe ventricular arrhythmias with amiodarone hydrochloride." | 7.66 | Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug. ( Rakita, L; Sobol, SM, 1982) |
| "The pretreatment of rats with amiodarone for 2 minutes to 3 weeks before the excision of their hearts caused a dose-related decrease in heart rate and an increase in the ventricular fibrillation threshold both before and after coronary arterial ligation." | 7.66 | Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. ( Lubbe, WF; McFadyen, ML; Muller, CA; Opie, LH; Worthington, M, 1979) |
| "The duration of arrhythmias induced by reperfusion following 5 min of ischaemia was also less in the rats which had received amiodarone than in the controls (43." | 5.28 | Amiodarone, adrenoceptor responsiveness and ischaemia- and reperfusion-induced arrhythmias. ( Chess-Williams, R; Coker, SJ, 1991) |
| " The Authors evaluated the prophylactic efficacy of the chronic administration of amiodarone (A) on this arrhythmia and simultaneously the trend of ventricular extrasystole during the antiarrhythmic treatment." | 5.28 | [Amiodarone prophylaxis of ventricular tachycardia in ischemic cardiopathy]. ( Bernasconi, M; Cirino, D; Marzegalli, M; Pogna, M; Potenza, S, 1989) |
| "Amiodarone was used in the treatment of 21 patients with supraventricular or ventricular arrhythmias which were refractory to conventional antiarrhythmic drugs, individually or in combination." | 5.27 | Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias. ( Best, JF; Dunn, M; Lynch, L; Rinkenberger, R, 1986) |
| "Oral amiodarone was evaluated in 24 patients with complex forms of ventricular premature depolarizations (VPD) by means of ECG monitoring and measurement of systolic time intervals." | 5.26 | Oral amiodarone in high-risk ventricular arrhythmias. ( Cabrera-Alonso, C; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A; Llerena, L; Ramos-Emperador, C; Sellén, J; Toruncha, A, 1982) |
| "In the AFIST III (Atrial Fibrillation Suppressions Trial III), anterior fat pad (AFP) retention did not decrease the incidence of postoperative atrial fibrillation (POAF), but prophylaxis with amiodarone did." | 5.13 | Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III). ( Coleman, CI; Dale, K; Gallagher, R; Henyan, N; Kluger, J; Reinhart, K; Sander, S; White, CM, 2008) |
| "Routine use of postoperative prophylactic intravenous bolus and subsequent 5 days of oral amiodarone therapy after coronary artery bypass grafting reduces the risk of atrial fibrillation and decreases the total costs of care by 175 euros per patient." | 5.13 | Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. ( Christensen, TD; Hjortdal, VE; Kristiansen, IS; Zebis, LR, 2008) |
| "The duration, severity, and cause of hypotension after intravenous amiodarone has not been well characterized in anesthetized cardiac surgical patients." | 5.10 | Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients. ( Augoustides, JG; Cheung, AT; Gardner, TJ; Harrington, A; Levy, WJ; Savino, JS; Weiss, SJ, 2003) |
| "Both amiodarone and beta-blockers have been shown to decrease the incidence of atrial fibrillation after cardiovascular surgery." | 5.09 | Amiodarone versus a beta-blocker to prevent atrial fibrillation after cardiovascular surgery. ( Greenberg, MD; Katz, NM; Kilborn, MJ; Solomon, AJ, 2001) |
| "Various regimens have been proposed for the prevention of postoperative atrial fibrillation, including the use of intravenous and oral amiodarone." | 5.09 | Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery. ( Babić, R; Bojić, M; Borzanović, M; Bosković, SD; Jovanović, T; Kovacević, S; Maras, D; Marinković, J; Nastasić, S; Nesković, AN; Otasević, P; Popović, AD; Popović, Z; Vuk, L, 2001) |
| "The effects of a 6-week treatment with amiodarone on the P-wave triggered signal-averaged electrocardiogram in patients with paroxysmal atrial fibrillation and coronary artery disease have been studied." | 5.09 | Effects of amiodarone on the P-wave triggered signal-averaged electrocardiogram in patients with paroxysmal atrial fibrillation and coronary artery disease. ( Adamus, J; Anker, SD; Banasiak, W; Coats, AJ; Fuglewicz, A; Kalka, D; Molenda, W; Ponikowski, P; Reczuch, K; Telichowski, A, 1999) |
| "The safety and efficacy of amiodarone and propafenone in converting atrial fibrillation or flutter after cardiac surgery were compared in a randomized double-blind trial." | 5.08 | Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. ( Cappiello, E; Di Biasi, P; Mangini, A; Paje, A; Santoli, C; Scrofani, R, 1995) |
| "We examined the chronic electrophysiologic, systemic, and pharmacologic effects of chronic oral amiodarone therapy in 24 patients with refractory ventricular tachycardia and organic heart disease." | 5.05 | Chronic effects of amiodarone in patients with refractory ventricular tachycardia. ( Cappello, G; Rothbart, ST; Saksena, S, 1983) |
| "Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation." | 4.88 | Mechanisms in endocrinology: Heart failure and thyroid dysfunction. ( Biondi, B, 2012) |
| "This study aimed to assess safety and cardiovascular outcomes of dronedarone in patients with paroxysmal or persistent atrial fibrillation (AF) with coronary heart disease (CHD)." | 3.80 | Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial. ( Connolly, SJ; Crijns, HJ; Hohnloser, SH; Naditch-Brûlé, L; Page, RL; Pisters, R; Torp-Pedersen, C, 2014) |
| "In patients with congestive heart failure on antiarrhythmic therapy, the SPAF trial has shown an increase in cardiac mortality and arrhythmic deaths." | 3.77 | Amiodarone as a first-line drug in the treatment of atrial fibrillation: the protagonist viewpoint. ( Lévy, S, 1994) |
| "The present study implies that initiation of amiodarone therapy in pts with structural heart disease and AF that are concomitantly treated with beta-blockers and digitalis may have an increased risk of amiodarone-associated pro-arrhythmia." | 3.73 | Pro-arrhythmic effects of amiodarone and concomitant rate-control medication. ( Bielik, H; Bitzen, A; Lewalter, T; Lüderitz, B; Schrickel, JW; Schwab, JO; Yang, A, 2006) |
| "The authors describe a case of a 74-year-old man with advanced coronary heart disease in whom pulmonary hemorrhagic complications during therapy with ticlopidine and subsequently with clopidogrel and amiodarone were observed." | 3.73 | [Recurrent hemoptysis following thienopyridines and amiodarone administration. therapeutic dilemma]. ( Cofta, S; Elikowski, W; Mańczak, J; Nowicki, A; Psuja, P, 2005) |
| " Data also suggest that amiodarone appears to be the safest antiarrhythmic drug for treatment sustained and nonsustained arrhythmias, and improved survival in patients with advanced heart failure." | 3.69 | [Pharmacologic treatment for ventricular arrhythmias]. ( Halawa, B, 1997) |
| ") administered amiodarone using four canine ventricular arrhythmia models." | 3.69 | Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia. ( Awaji, T; Hashimoto, K; Wu, ZJ, 1995) |
| "A group of 34 consecutive patients with coronary artery disease (n = 29) or dilated cardiomyopathy (n = 5) (3 women, 31 men, age 38-80 yr) who had severely impaired left ventricular function (left ventricular ejection fraction less than or equal to 40%) and high-grade ventricular ectopic activity (sustained or nonsustained ventricular tachycardia or ventricular fibrillation) were treated with amiodarone (mean dose: 206 mg/d) and followed for 1-117 (mean: 49) months." | 3.68 | Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction. ( Burckhardt, D; Hoffmann, A; Pfisterer, M; Robertson, A, 1991) |
| "The authors suggest a new method of choice of the drug (quinidine or cordarone) for the maintenance antiarrhythmic therapy after sinus rhythm recovery in patients with permanent atrial fibrillation, in patients with rheumatic heart disease and coronary heart disease." | 3.68 | [A method of choosing maintenance anti-arrhythmia therapy after sinus rhythm restoration in patients with a permanent form of atrial fibrillation]. ( Alekseevskaia, MA; Maevskaia, IV; Nedostup, AV, 1991) |
| " The patient was discharged with digitalis, nitrates, aspirin and amiodarone for prophylactic treatment of paroxystic atrial fibrillation." | 3.68 | [Ventricular fibrillation during stress test on a treadmill. Apropos of a case]. ( Baroffio, R; Croce, A; Tisi, G, 1993) |
| "We undertook this study to determine if the cycle-length response of ventricular tachycardia (VT) to procainamide and amiodarone is similar in the individual patient." | 3.68 | Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone. ( Buxton, AE; Josephson, ME; Marchlinski, FE; Vaitkus, PT, 1990) |
| "This study was undertaken to determine whether prolonged QTc interval as a consequence of abnormal repolarization induced by coronary disease or antiarrhythmic drugs could be shortened by intravenous administration of magnesium sulfate." | 3.68 | Abnormal QT intervals associated with negative T waves induced by antiarrhythmic drugs are rapidly reduced using magnesium sulfate as an antidote. ( Gurfinkel, E; Mautner, B; Pazos, AA, 1993) |
| "Amiodarone was administered orally to 30 patients with chronic stable coronary artery disease and severe ventricular arrhythmias." | 3.67 | Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease. ( Elizari, MV; Girotti, LA; Goldbarg, A; Kaski, JC; Lázzari, JO; Rosenbaum, MB; Tambussi, A, 1984) |
| "Amiodarone was used in 86 patients with ventricular tachycardia (VT) (67 patients) or ventricular fibrillation (19 patients) secondary to coronary artery disease." | 3.67 | Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone. ( Estes, NA; Manolis, AS; Uricchio, F, 1989) |
| "This study examined the effectiveness of intravenous amiodarone for rapid control and prevention of recurrent life-threatening ventricular tachyarrhythmias associated with cardiovascular collapse." | 3.67 | Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease. ( Almquist, A; Benditt, DG; Gobel, FL; Goldenberg, IF; Milstein, S; Ochi, RP; Pedersen, W; Pritzker, M, 1989) |
| "The prognostic importance of electrophysiologic studies in patients with sustained ventricular tachyarrhythmias treated with amiodarone was prospectively studied in 100 consecutive patients." | 3.67 | Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. ( Greenspan, AM; Horowitz, LN; Kay, HR; Morganroth, J; Rae, AP; Rotmensch, H; Segal, BL; Sokoloff, NM; Spielman, SR; Webb, CR, 1985) |
| " The aim of our study was to evaluate the effects of amiodarone (400 mg day-1 for seven days and then 200 mg day-1, five days a week, for 60 days) in 20 patients with chronic ischaemic heart disease ascertained by stress test, thallium-201 myocardial scintigraphy and coronary angiography and with qualitatively and quantitatively similar cardiac arrhythmias in two continuous ECG monitoring sessions performed before starting treatment." | 3.67 | Effects of low doses of amiodarone on cardiac arrhythmias in patients with chronic ischaemic heart disease. ( Abrignani, MG; Alaimo, G; Cutietta, A; Immordino, R; Indovina, A; Licata, G; Novo, S; Strano, A, 1988) |
| "A case of pulmonary fibrosis attributed to amiodarone was studied immunologically and morphologically." | 3.67 | Amiodarone-associated pulmonary fibrosis. Evidence of an immunologically mediated mechanism. ( Bell, R; Eudy, S; Fan, K; Fullenwider, J, 1987) |
| "Induction of ventricular tachycardia (VT) at electrophysiologic study in patients taking amiodarone poorly predicts recurrence of VT." | 3.67 | Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrop ( Chang, MS; Fineberg, N; Heger, JJ; Kammerling, JM; Klein, LS; Miles, WM; Prystowsky, EN; Zipes, DP, 1988) |
| "The effect of intravenous (IV) amiodarone (300 mg) on heart rate was investigated in 22 patients with acute myocardial infarction (18) or ischemia (4) and sinus tachycardia." | 3.67 | The effect of intravenous amiodarone on heart rate in patients with acute myocardial infarction or ischemia and sinus tachycardia. ( Agmon, J; Klainman, E; Kusniec, J; Sclarovsky, S; Strasberg, B, 1988) |
| "The value of serial electropharmacologic testing during long-term oral amiodarone therapy for prediction of long-term drug efficacy as well as characteristics of arrhythmia recurrence is controversial." | 3.67 | Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease. ( DiMarco, JP; Haines, DE; Lerman, BB; Zhu, J, 1987) |
| "The main goal of this project was to study the effect of amiodarone upon ventricular fibrillation and defibrillation thresholds (VFT and VDT) in the canine heart under normal and ischemic conditions." | 3.67 | Effect of amiodarone on ventricular fibrillation and defibrillation thresholds in the canine heart under normal and ischemic conditions. ( Arredondo, MT; Guillen, SG; Quinteiro, RA, 1986) |
| "The values of two Holter ambulatory electrocardiographic monitoring criteria and one programmed stimulation efficacy criterion reported to be predictive of the efficacy of amiodarone were compared in 70 patients taking amiodarone for sustained ventricular tachyarrhythmias." | 3.67 | Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia. ( Felder, SD; Figura, I; Fisher, JD; Johnston, DR; Kim, SG; Waspe, LE, 1987) |
| "Over a 10-year period 130 patients with drug-resistant cardiac arrhythmias associated mainly with coronary artery disease and its complications were treated with amiodarone." | 3.67 | Amiodarone for refractory cardiac arrhythmias: 10-year study. ( Eydt, JN; Leak, D, 1986) |
| "To assess and compare the hemodynamic profile of short-and long-term amiodarone administration in the same set of patients and to investigate hemodynamic mechanisms responsible for the antianginal effect of this drug, 10 patients with documented coronary artery disease and stable angina pectoris were studied." | 3.67 | Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction. ( Burkart, F; Kiowski, W; Müller-Brand, J; Pfisterer, M, 1985) |
| "A case of pneumonitis and pulmonary fibrosis occurring during long term treatment with amiodarone hydrochloride is described." | 3.67 | Lung disease associated with amiodarone treatment. ( Cosentino, G; De Vuono, T; Pesola, A; Vercillo, C, 1985) |
| "The effects of amiodarone and its metabolite desethylamiodarone on arrhythmias induced by ischaemia and reperfusion were studied in vivo in the anaesthetised rat with transient regional ischaemia (7 min of left coronary artery occlusion) and reperfusion (10 min)." | 3.67 | Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat. ( Hearse, DJ; Riva, E, 1989) |
| "Six patients are presented who developed pulmonary infiltrates of undetermined origin while being treated for severe ventricular arrhythmias with amiodarone hydrochloride." | 3.66 | Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug. ( Rakita, L; Sobol, SM, 1982) |
| "The pretreatment of rats with amiodarone for 2 minutes to 3 weeks before the excision of their hearts caused a dose-related decrease in heart rate and an increase in the ventricular fibrillation threshold both before and after coronary arterial ligation." | 3.66 | Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. ( Lubbe, WF; McFadyen, ML; Muller, CA; Opie, LH; Worthington, M, 1979) |
| "Treatment with amiodarone results in significant QT prolongation without altering QT dispersion." | 2.68 | Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome. ( Helguera, ME; Kidwell, GA; Meierhenrich, R; Tebbe, U, 1997) |
| "Sustained hemodynamically tolerated ventricular tachycardia (HTVT) comprises up to 30% of all cases of monomorphic ventricular tachycardia in patients with CAD." | 2.43 | Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease? ( Arya, A; Haghjoo, M; Sadr-Ameli, MA, 2005) |
| "Amiodarone is a viable drug for preventing sudden cardiac death, particularly during the first year after MI." | 2.38 | Amiodarone and post-MI patients. ( Nademanee, K; Singh, BN; Stevenson, WG; Weiss, JN, 1993) |
| "Amiodarone has been demonstrated to be an important and effective antiarrhythmic agent, as has sotalol." | 2.38 | Empiric use of amiodarone and sotalol. ( Nora, M; Zipes, DP, 1993) |
| "The novel arrhythmia model induced by coronary artery occlusion in hyperlipidemic rats is reliable and similar to the pathophysiological state in human being." | 1.33 | [Establishment of a novel arrhythmia model in rats]. ( Dong, DL; Du, ZM; Jiao, JD; Pan, ZW; Wang, ZY; Yang, BF, 2005) |
| "Amiodarone-induced torsades de pointes is very rare." | 1.29 | ['Cardiac ballet' with and without amiodarone]. ( Balestra, B; Hess, T, 1993) |
| "Amiodarone is a powerful suppressant of VPCs, but Holter suppression of this ectopic activity is not predictive of clinical outcome." | 1.29 | Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease. ( Doyle, TK; Nasir, N; Pacifico, A; Wheeler, SH, 1994) |
| "Fifteen patients with spontaneous ventricular tachyarrhythmias underwent electrophysiologic studies at baseline and during therapy with quinidine and amiodarone." | 1.29 | Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease. ( Almendral, JM; Arenal, A; Delcán, JL; Lorca, MT; Pastor, A, 1993) |
| "Amiodarone hydrochloride is an antiarrhythmic agent useful in arrhythmias refractory to standard therapy." | 1.28 | Pulmonary complications after long term amiodarone treatment. ( Heras, M; Magriñà, J; Roca, J; Rodriguez-Roisin, R; Sanz, G; Xaubet, A, 1992) |
| "The duration of arrhythmias induced by reperfusion following 5 min of ischaemia was also less in the rats which had received amiodarone than in the controls (43." | 1.28 | Amiodarone, adrenoceptor responsiveness and ischaemia- and reperfusion-induced arrhythmias. ( Chess-Williams, R; Coker, SJ, 1991) |
| "Treatment with amiodarone did not appear to influence survival." | 1.28 | Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. ( Baron, DW; Hickie, JB; Keogh, AM, 1990) |
| "Amiodarone was then reintroduced and four years later, the patient developed hepatomegaly, worsening liver biochemistry and histopathological changes consistent with early cirrhosis." | 1.28 | Hepatotoxicity of amiodarone. ( Jeyamalar, R; Kannan, P; Pathmanathan, R; Wong, D, 1992) |
| " The Authors evaluated the prophylactic efficacy of the chronic administration of amiodarone (A) on this arrhythmia and simultaneously the trend of ventricular extrasystole during the antiarrhythmic treatment." | 1.28 | [Amiodarone prophylaxis of ventricular tachycardia in ischemic cardiopathy]. ( Bernasconi, M; Cirino, D; Marzegalli, M; Pogna, M; Potenza, S, 1989) |
| "Amiodarone was used in the treatment of 21 patients with supraventricular or ventricular arrhythmias which were refractory to conventional antiarrhythmic drugs, individually or in combination." | 1.27 | Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias. ( Best, JF; Dunn, M; Lynch, L; Rinkenberger, R, 1986) |
| " Dose-response studies were performed at concentrations of 0." | 1.27 | Myocardial protective effect of amiodarone in hypertrophied hearts during global ischemia. ( Clark, RE; Jones, M; Takach, TJ; Voigtlander, JP, 1986) |
| "Amiodarone therapy was initiated with a 5 mg/kg infusion followed by 600 to 800 mg/day for 7 to 10 days, then 200 to 400 mg/day." | 1.27 | Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity. ( Benaderet, D; Blevins, RD; Faitel, K; Garfinkel, C; Jarandilla, R; Kerin, NZ; Klein, S; Rubenfire, M, 1986) |
| "The amiodarone group was older, with worse left ventricular function and more peripheral and cerebrovascular disease." | 1.27 | Comparison of survival of amiodarone-treated patients with coronary artery disease and malignant ventricular arrhythmias with that of a control group with coronary artery disease. ( German, LD; Gilbert, MR; Harrell, FE; Kay, GN; Lee, KL; Pressley, JC; Pryor, DB, 1987) |
| " Sixty-three patients (55%) had one or more adverse effects attributed to amiodarone." | 1.27 | Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity. ( DiMarco, JP; Greenberg, ML; Kaiser, DL; Lerman, BB; Shipe, JR, 1987) |
| "Protection from arrhythmias seems to be related to the combined presence of a noncompetitive adrenergic blockade associated with salutary effects on coronary circulation." | 1.27 | The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity. ( Schwartz, PJ; Vanoli, E; Zaza, A; Zuanetti, G, 1985) |
| "cent of cases of supraventricular arrhythmia and in 92." | 1.27 | [Efficacy and side effects of long-term treatment with amiodarone. Retrospective study. Apropos of 460 cases]. ( Farges, D; Fontaine, G; Frank, R; Grosgogeat, Y; Komajda, M; Michat, L, 1985) |
| "Amiodarone was given to 17 patients with drug refractory sustained ventricular arrhythmias." | 1.27 | Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness. ( Alpert, MA; Flaker, GC; Ruder, MA; Sanfelippo, JF; Tsutakawa, RK; Webel, RR, 1985) |
| "After treatment of ischemia and/or failure, specific antiarrhythmic agents, conventional and investigational, alone or in combination, are systematically selected." | 1.26 | Ventricular ectopy: etiology, evaluation, and therapy. ( Reid, PR; Vlay, SC, 1982) |
| "Amiodarone is a drug which is frequently used in cardiology, and which can lead to the appearance of hyper- of hypo-thyroidism in certain cases." | 1.26 | [Amiodarone and thyroid function]. ( Bernard, R; Blockx, P; Broeckaert, I; Jonckheer, MH, 1976) |
| "Oral amiodarone was evaluated in 24 patients with complex forms of ventricular premature depolarizations (VPD) by means of ECG monitoring and measurement of systolic time intervals." | 1.26 | Oral amiodarone in high-risk ventricular arrhythmias. ( Cabrera-Alonso, C; García-Barreto, D; González-Gómez, A; Hernández-Cañero, A; Llerena, L; Ramos-Emperador, C; Sellén, J; Toruncha, A, 1982) |
| " In spite of the high iodine content, amiodarone does not, therefore, depress thyroid function to any important degree during chronic administration and its antianginal action does not appear to be caused by the production of generalized hypothyroidism." | 1.25 | Effects of amiodarone on thyroid function in patients with ischaemic heart disease. ( Hurley, PJ; Pritchard, DA; Singh, BN, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 110 (58.20) | 18.7374 |
| 1990's | 53 (28.04) | 18.2507 |
| 2000's | 21 (11.11) | 29.6817 |
| 2010's | 5 (2.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pisters, R | 1 |
| Hohnloser, SH | 2 |
| Connolly, SJ | 1 |
| Torp-Pedersen, C | 1 |
| Naditch-Brûlé, L | 1 |
| Page, RL | 1 |
| Crijns, HJ | 1 |
| Naccarelli, GV | 1 |
| Stiefelhagen, P | 2 |
| Thomas, SP | 1 |
| Olesin, AI | 1 |
| Smolin, ZIu | 1 |
| Konovalova, OA | 1 |
| Shabrov, AV | 1 |
| Michalski, T | 1 |
| Biondi, B | 1 |
| Grönefeld, GC | 1 |
| Kasanuki, H | 1 |
| Cheung, AT | 1 |
| Weiss, SJ | 1 |
| Savino, JS | 1 |
| Levy, WJ | 1 |
| Augoustides, JG | 1 |
| Harrington, A | 1 |
| Gardner, TJ | 1 |
| Yazigi, A | 1 |
| Haddad, F | 1 |
| Madi-Jebara, S | 1 |
| Sleilaty, G | 1 |
| Jebara, VA | 1 |
| Kulasingam, SL | 1 |
| Akiyama, T | 1 |
| Mounsey, JP | 1 |
| Ledingham, R | 1 |
| Hallstrom, AP | 1 |
| Khalil, SI | 1 |
| Kamal, A | 1 |
| Ahmad, S | 1 |
| Arya, A | 1 |
| Haghjoo, M | 1 |
| Sadr-Ameli, MA | 1 |
| Pan, ZW | 1 |
| Wang, ZY | 1 |
| Du, ZM | 1 |
| Jiao, JD | 1 |
| Dong, DL | 1 |
| Yang, BF | 1 |
| Schrickel, JW | 1 |
| Schwab, JO | 1 |
| Yang, A | 1 |
| Bielik, H | 1 |
| Bitzen, A | 1 |
| Lüderitz, B | 3 |
| Lewalter, T | 1 |
| Elikowski, W | 1 |
| Cofta, S | 1 |
| Nowicki, A | 1 |
| Mańczak, J | 1 |
| Psuja, P | 1 |
| Reĭngardene, DI | 1 |
| Pil'vinis, VK | 1 |
| White, CM | 2 |
| Sander, S | 2 |
| Coleman, CI | 2 |
| Gallagher, R | 2 |
| Takata, H | 1 |
| Humphrey, C | 1 |
| Henyan, N | 2 |
| Gillespie, EL | 1 |
| Kluger, J | 2 |
| Dale, K | 1 |
| Reinhart, K | 1 |
| Zebis, LR | 1 |
| Christensen, TD | 1 |
| Kristiansen, IS | 1 |
| Hjortdal, VE | 1 |
| Bloch, A | 1 |
| Sidorenko, BA | 2 |
| Liakishev, AA | 1 |
| Vlay, SC | 1 |
| Reid, PR | 1 |
| Zhivoderov, VM | 1 |
| Zakharov, VN | 1 |
| Doshchitsin, VL | 1 |
| Aksenova, TN | 1 |
| Andriukova, EI | 1 |
| Markov, KV | 1 |
| Sapozhnikov, AA | 1 |
| Anshelevich, IuV | 1 |
| Kalvelis, AD | 1 |
| Orlova, VP | 1 |
| Rubin, AI | 1 |
| Sporan, VG | 1 |
| Saksena, S | 2 |
| Rothbart, ST | 1 |
| Cappello, G | 1 |
| Manresa, F | 1 |
| Garau, J | 1 |
| Gausí, C | 1 |
| Sanmartí, A | 1 |
| Permanyer-Miralda, G | 2 |
| Castellanos, JM | 1 |
| Foz-Sala, M | 1 |
| Galard, RM | 1 |
| Soler-Soler, J | 1 |
| Grigor'eva, NN | 1 |
| Gichka, SG | 1 |
| Stepaniuk, GI | 1 |
| Degtiareva, LV | 1 |
| Markiewicz, M | 2 |
| Tomaszewski, A | 1 |
| Sokoluk, I | 1 |
| Farmakis, M | 1 |
| Litos, G | 1 |
| Melissinos, C | 1 |
| Vic, P | 1 |
| Patterson, E | 1 |
| Eller, BT | 1 |
| Abrams, GD | 1 |
| Vasiliades, J | 1 |
| Lucchesi, BR | 1 |
| Cherevatov, BG | 1 |
| Kucherenko, OD | 1 |
| Boiarshin, SV | 1 |
| Halawa, B | 2 |
| Kaski, JC | 1 |
| Girotti, LA | 1 |
| Elizari, MV | 1 |
| Lázzari, JO | 1 |
| Goldbarg, A | 1 |
| Tambussi, A | 1 |
| Rosenbaum, MB | 1 |
| Hoffmann, A | 2 |
| Schütz, E | 1 |
| White, R | 1 |
| Follath, F | 1 |
| Burckhardt, D | 2 |
| Wysokiński, A | 1 |
| Rymar, B | 1 |
| Wilkołaski, J | 1 |
| Grzywa, R | 1 |
| Wójcik, J | 1 |
| Sung, RJ | 1 |
| Shen, EN | 1 |
| Morady, F | 3 |
| Scheinman, MM | 1 |
| Hess, D | 1 |
| Botvinick, EH | 1 |
| Khalfen, ESh | 1 |
| Shvarts, IL | 1 |
| Shigin, IuN | 1 |
| Klochkov, VA | 1 |
| Temkin, BM | 1 |
| Vitolo, E | 1 |
| Tronci, M | 1 |
| Larovere, MT | 1 |
| Rumolo, R | 1 |
| Morabito, A | 1 |
| Sobol, SM | 2 |
| Rakita, L | 2 |
| Toruncha, A | 1 |
| García-Barreto, D | 1 |
| González-Gómez, A | 1 |
| Llerena, L | 1 |
| Sellén, J | 1 |
| Ramos-Emperador, C | 1 |
| Cabrera-Alonso, C | 1 |
| Hernández-Cañero, A | 1 |
| Achilli, A | 1 |
| Giacci, M | 1 |
| Capezzuto, A | 1 |
| De Luca, F | 1 |
| Guerra, R | 1 |
| Serra, N | 1 |
| Manfroi, WC | 1 |
| de Freitas, FM | 1 |
| de Azevedo, DF | 1 |
| Faraco, EZ | 1 |
| Breithardt, G | 2 |
| Seipel, L | 1 |
| Kuhn, H | 1 |
| Martínez-Rubio, A | 1 |
| Shenasa, M | 1 |
| Chen, X | 1 |
| Wichter, T | 1 |
| Borggrefe, M | 1 |
| Nasir, N | 1 |
| Doyle, TK | 1 |
| Wheeler, SH | 1 |
| Pacifico, A | 1 |
| Pitton, MB | 1 |
| Schweden, F | 1 |
| Lenci, G | 1 |
| Nademanee, K | 1 |
| Singh, BN | 3 |
| Stevenson, WG | 1 |
| Weiss, JN | 1 |
| Ammar, A | 1 |
| Wong, M | 1 |
| Cheng, TO | 1 |
| Lévy, S | 1 |
| Nora, M | 1 |
| Zipes, DP | 3 |
| Pastor, A | 1 |
| Almendral, JM | 1 |
| Arenal, A | 1 |
| Lorca, MT | 1 |
| Delcán, JL | 1 |
| Russo, AM | 1 |
| Beauregard, LM | 1 |
| Waxman, HL | 1 |
| Tisi, G | 1 |
| Baroffio, R | 1 |
| Croce, A | 1 |
| Gurfinkel, E | 1 |
| Pazos, AA | 1 |
| Mautner, B | 1 |
| Balestra, B | 1 |
| Hess, T | 1 |
| Ducceschi, V | 1 |
| Sarubbi, B | 1 |
| Esposito, R | 1 |
| Manzo, G | 1 |
| Mayer, MS | 1 |
| Santangelo, L | 1 |
| Iacono, A | 1 |
| Di Biasi, P | 1 |
| Scrofani, R | 1 |
| Paje, A | 1 |
| Cappiello, E | 1 |
| Mangini, A | 1 |
| Santoli, C | 1 |
| Awaji, T | 1 |
| Wu, ZJ | 1 |
| Hashimoto, K | 1 |
| Matiouchine, GV | 1 |
| Shulman, VA | 1 |
| Balog, AI | 1 |
| Bezruk, AP | 1 |
| Golovenkin, SE | 1 |
| Leipner, N | 1 |
| Schüller, H | 1 |
| Liesenfeld, H | 1 |
| Noé, G | 1 |
| Tschubel, K | 1 |
| Muratore, C | 1 |
| Rabinovich, R | 1 |
| Iglesias, R | 1 |
| González, M | 1 |
| Darú, V | 1 |
| Liprandi, AS | 1 |
| Neuzner, J | 1 |
| Bahawar, H | 1 |
| Berkowitsch, A | 1 |
| Michel, U | 1 |
| Schlepper, M | 1 |
| Pitschner, HF | 1 |
| Meierhenrich, R | 1 |
| Helguera, ME | 1 |
| Kidwell, GA | 1 |
| Tebbe, U | 1 |
| Giorgberidze, I | 1 |
| Krol, RB | 1 |
| Munsif, AN | 1 |
| Kolettis, T | 1 |
| Mathew, P | 1 |
| Varanasi, S | 1 |
| Prakash, A | 1 |
| Delfaut, P | 1 |
| Lewis, CB | 1 |
| Myerburg, RJ | 1 |
| Castellanos, A | 1 |
| Piazza, V | 1 |
| Rulli, F | 1 |
| Banasiak, W | 1 |
| Telichowski, A | 1 |
| Anker, SD | 1 |
| Fuglewicz, A | 1 |
| Kalka, D | 1 |
| Molenda, W | 1 |
| Reczuch, K | 1 |
| Adamus, J | 1 |
| Coats, AJ | 1 |
| Ponikowski, P | 1 |
| Kovoor, P | 1 |
| Eipper, V | 1 |
| Byth, K | 1 |
| Cooper, MJ | 1 |
| Uther, JB | 1 |
| Ross, DL | 1 |
| Naccarella, F | 1 |
| Rolli, A | 1 |
| Carboni, A | 1 |
| Finardi, A | 1 |
| Aurier, E | 1 |
| Favaro, L | 1 |
| Contini, S | 1 |
| Gherli, T | 1 |
| Caponi, D | 1 |
| Maranga, SS | 1 |
| Lepera, G | 1 |
| Bartoletti, A | 1 |
| Copie, X | 1 |
| Piot, O | 1 |
| Said, MA | 1 |
| Lavergne, T | 1 |
| Ollitrault, J | 1 |
| Guize, L | 1 |
| Le Heuzey, JY | 1 |
| Aggarwal, A | 1 |
| Maras, D | 1 |
| Bosković, SD | 1 |
| Popović, Z | 1 |
| Nesković, AN | 1 |
| Kovacević, S | 1 |
| Otasević, P | 1 |
| Marinković, J | 1 |
| Vuk, L | 1 |
| Borzanović, M | 1 |
| Nastasić, S | 1 |
| Jovanović, T | 1 |
| Bojić, M | 1 |
| Babić, R | 1 |
| Popović, AD | 1 |
| Solomon, AJ | 1 |
| Greenberg, MD | 1 |
| Kilborn, MJ | 1 |
| Katz, NM | 1 |
| Kim, MH | 1 |
| Rachwal, W | 1 |
| McHale, C | 1 |
| Bruckman, D | 1 |
| Decena, BF | 1 |
| Russman, P | 1 |
| Eagle, KA | 1 |
| Metelitsa, VI | 1 |
| Matveeva, LS | 1 |
| Borisova, GA | 1 |
| Lupanov, VP | 2 |
| Delage, C | 1 |
| Lagacé, R | 1 |
| Huard, J | 1 |
| Broustet, JP | 1 |
| Griffo, R | 1 |
| Seriès, E | 1 |
| Guern, P | 1 |
| Laylavoix, F | 1 |
| Lubbe, WF | 1 |
| McFadyen, ML | 1 |
| Muller, CA | 1 |
| Worthington, M | 1 |
| Opie, LH | 1 |
| De'Thomatis, M | 1 |
| Falciola, N | 1 |
| Gallesio, R | 1 |
| Zhmurkin, VP | 1 |
| Zamotaev, IP | 1 |
| Troshina, TF | 1 |
| Côté, P | 1 |
| Bourassa, MG | 1 |
| Delaye, J | 1 |
| Janin, A | 1 |
| Froment, R | 1 |
| David, P | 1 |
| Guibradze, T | 1 |
| Kobaladze, S | 1 |
| Isakadze, A | 1 |
| Vacheron, A | 1 |
| Kuz'ko, NV | 1 |
| Jonckheer, MH | 1 |
| Broeckaert, I | 1 |
| Blockx, P | 1 |
| Bernard, R | 1 |
| Ourbak, P | 1 |
| Rocher, R | 1 |
| Aziza, JP | 1 |
| Manin, JP | 1 |
| Vagner, D | 1 |
| Leclerc, M | 1 |
| Maurice, P | 1 |
| Marchi, F | 1 |
| Kukes, VG | 1 |
| Cherkashina, TG | 1 |
| Semenov, VN | 1 |
| Borisov, VG | 1 |
| Borovkov, AI | 1 |
| Modica, G | 1 |
| Ferrante, R | 1 |
| Husson, J | 1 |
| Pritchard, DA | 1 |
| Hurley, PJ | 1 |
| Rizzon, P | 3 |
| Di Biase, M | 1 |
| Jeyamalar, R | 1 |
| Pathmanathan, R | 1 |
| Wong, D | 1 |
| Kannan, P | 1 |
| Chiamvimonvat, N | 1 |
| Mitchell, LB | 1 |
| Gillis, AM | 1 |
| Wyse, DG | 1 |
| Sheldon, RS | 1 |
| Duff, HJ | 1 |
| Epstein, AE | 1 |
| Ellenbogen, KA | 1 |
| Kirk, KA | 1 |
| Kay, GN | 2 |
| Dailey, SM | 1 |
| Plumb, VJ | 1 |
| Calkins, H | 1 |
| Shyr, Y | 1 |
| Schork, A | 1 |
| Kadish, A | 1 |
| Krieg, P | 1 |
| Schipper, I | 1 |
| Roca, J | 2 |
| Heras, M | 1 |
| Rodriguez-Roisin, R | 2 |
| Magriñà, J | 1 |
| Xaubet, A | 2 |
| Sanz, G | 1 |
| Shaikh, NA | 1 |
| Coker, SJ | 1 |
| Chess-Williams, R | 1 |
| Legrand, V | 1 |
| Vander Elst, L | 1 |
| Goudemant, JF | 1 |
| Mouton, J | 2 |
| Chatelain, P | 2 |
| Van Haverbeke, Y | 1 |
| Muller, RN | 1 |
| Goedel-Meinen, L | 3 |
| Hofmann, M | 2 |
| Schmidt, G | 3 |
| Maier-Rudolph, W | 2 |
| Barthel, P | 2 |
| Schrag, A | 2 |
| Baedeker, W | 3 |
| Blömer, H | 3 |
| Robertson, A | 1 |
| Pfisterer, M | 3 |
| Nedostup, AV | 1 |
| Alekseevskaia, MA | 1 |
| Maevskaia, IV | 1 |
| Lakhdar, AA | 1 |
| Farish, E | 1 |
| Hillis, WS | 1 |
| Dunn, FG | 1 |
| Remme, WJ | 3 |
| Kruyssen, HA | 1 |
| Look, MP | 1 |
| van Hoogenhuyze, DC | 3 |
| Krauss, XH | 3 |
| Dabrowski, A | 1 |
| Ostrowska, B | 1 |
| Bacior, B | 1 |
| Fryśna-Dmuchowska, B | 1 |
| Kargul, W | 1 |
| Król, J | 1 |
| Królikowski, Z | 1 |
| Luczak, D | 1 |
| Malczewska, B | 1 |
| Nessler, J | 1 |
| Keogh, AM | 1 |
| Baron, DW | 1 |
| Hickie, JB | 1 |
| Campbell, TJ | 1 |
| Hemsworth, PD | 1 |
| Giardina, EG | 1 |
| Schneider, M | 1 |
| Barr, ML | 1 |
| Sano, T | 1 |
| Sugiyama, S | 1 |
| Taki, K | 1 |
| Hanaki, Y | 1 |
| Shimada, Y | 1 |
| Ozawa, T | 1 |
| Nitsch, J | 1 |
| Leffler, J | 1 |
| Stewart, D | 1 |
| Finch, N | 1 |
| Kratz, J | 1 |
| Leman, RB | 1 |
| Vaitkus, PT | 1 |
| Buxton, AE | 1 |
| Josephson, ME | 1 |
| Marchlinski, FE | 1 |
| Best, JF | 1 |
| Rinkenberger, R | 1 |
| Lynch, L | 1 |
| Dunn, M | 1 |
| Greenberg, ML | 2 |
| Lerman, BB | 3 |
| Haines, DE | 2 |
| Baron, JA | 1 |
| Dimarco, JP | 3 |
| Riva, E | 1 |
| Hearse, DJ | 1 |
| Aomine, M | 1 |
| Goldstein, S | 1 |
| Manolis, AS | 1 |
| Uricchio, F | 1 |
| Estes, NA | 1 |
| Bernasconi, M | 1 |
| Pogna, M | 1 |
| Potenza, S | 1 |
| Marzegalli, M | 1 |
| Cirino, D | 1 |
| Ochi, RP | 1 |
| Goldenberg, IF | 1 |
| Almquist, A | 1 |
| Pritzker, M | 1 |
| Milstein, S | 1 |
| Pedersen, W | 1 |
| Gobel, FL | 1 |
| Benditt, DG | 1 |
| Alpert, JS | 1 |
| Nekrutman, EA | 1 |
| Kulikova, TV | 1 |
| Podinovskaia, IaA | 1 |
| Vomácka, Z | 1 |
| Válka, L | 1 |
| Cobbe, SM | 2 |
| Manley, BS | 2 |
| Jahns, G | 1 |
| Klein, G | 1 |
| Wirtzfeld, A | 1 |
| González, R | 1 |
| Mercadal, E | 1 |
| Alburquerque, J | 1 |
| Martínez, A | 1 |
| Novo, S | 1 |
| Alaimo, G | 1 |
| Abrignani, MG | 1 |
| Immordino, R | 1 |
| Cutietta, A | 1 |
| Indovina, A | 1 |
| Licata, G | 1 |
| Strano, A | 1 |
| Kurbanov, RD | 1 |
| Kiiakbaev, GK | 1 |
| Fan, K | 1 |
| Bell, R | 1 |
| Eudy, S | 1 |
| Fullenwider, J | 1 |
| Klein, LS | 1 |
| Fineberg, N | 1 |
| Heger, JJ | 2 |
| Miles, WM | 2 |
| Kammerling, JM | 1 |
| Chang, MS | 1 |
| Prystowsky, EN | 2 |
| Cascio, WE | 1 |
| Woelfel, A | 1 |
| Knisley, SB | 1 |
| Buchanan, JW | 1 |
| Foster, JR | 1 |
| Gettes, LS | 1 |
| Jánosi, A | 1 |
| Tarján, Z | 1 |
| Kusniec, J | 1 |
| Strasberg, B | 1 |
| Sclarovsky, S | 1 |
| Klainman, E | 1 |
| Agmon, J | 1 |
| Pollak, PT | 1 |
| Sharma, AD | 1 |
| Carruthers, SG | 1 |
| Gremel, M | 1 |
| Brotelle, R | 1 |
| Herranz, J | 1 |
| Marin, A | 1 |
| Lomeña, F | 1 |
| Montserrat, JM | 1 |
| Agustí-Vidal, A | 1 |
| Lo, HM | 1 |
| Lin, FY | 1 |
| Chiang, FT | 1 |
| Tseng, CD | 1 |
| Tseng, YZ | 1 |
| Wu, TL | 1 |
| Pryor, DB | 1 |
| Lee, KL | 1 |
| Harrell, FE | 1 |
| Pressley, JC | 1 |
| Gilbert, MR | 1 |
| German, LD | 1 |
| Shipe, JR | 1 |
| Kaiser, DL | 1 |
| Nokin, P | 1 |
| Jungbluth, L | 1 |
| Zhu, J | 1 |
| Takach, TJ | 1 |
| Voigtlander, JP | 1 |
| Jones, M | 1 |
| Clark, RE | 1 |
| Lupon-Rosés, J | 1 |
| Simó-Canonge, R | 1 |
| Lu-Cortez, L | 1 |
| Allende-Monclús, H | 1 |
| Schwartz, PJ | 2 |
| Vanoli, E | 2 |
| Arredondo, MT | 1 |
| Guillen, SG | 1 |
| Quinteiro, RA | 1 |
| Rotstein, Z | 1 |
| Schneeweiss, A | 1 |
| Shotan, A | 1 |
| Har-Zahav, Y | 1 |
| Rath, S | 1 |
| Battler, A | 1 |
| Neufeld, HN | 1 |
| Guarino, H | 1 |
| Gensous, D | 1 |
| Kim, SG | 1 |
| Felder, SD | 1 |
| Figura, I | 1 |
| Johnston, DR | 1 |
| Waspe, LE | 1 |
| Fisher, JD | 1 |
| Ollagnier, M | 1 |
| Burkart, F | 2 |
| Donaghue, KC | 1 |
| Clarke, P | 1 |
| Hooper, MJ | 1 |
| Bekhbudova, DA | 1 |
| Kokurina, EV | 1 |
| Ostrovskaia, TP | 1 |
| Bochkareva, EV | 1 |
| Urumbaev, RK | 1 |
| Adams, PC | 1 |
| Holt, DW | 1 |
| Storey, GC | 1 |
| Morley, AR | 1 |
| Callaghan, J | 1 |
| Campbell, RW | 1 |
| Dorian, P | 1 |
| Furkalo, NK | 1 |
| Ivashchenko, TI | 1 |
| Romanenko, AI | 1 |
| Skale, BT | 1 |
| Kerin, NZ | 1 |
| Blevins, RD | 1 |
| Benaderet, D | 1 |
| Faitel, K | 1 |
| Jarandilla, R | 1 |
| Garfinkel, C | 1 |
| Klein, S | 1 |
| Rubenfire, M | 1 |
| Waldecker, B | 1 |
| Brugada, P | 1 |
| Zehender, M | 1 |
| Stevenson, W | 1 |
| Den Dulk, K | 1 |
| Wellens, HJ | 1 |
| Leak, D | 1 |
| Eydt, JN | 1 |
| Horowitz, LN | 1 |
| Greenspan, AM | 1 |
| Spielman, SR | 1 |
| Webb, CR | 1 |
| Morganroth, J | 1 |
| Rotmensch, H | 1 |
| Sokoloff, NM | 1 |
| Rae, AP | 1 |
| Segal, BL | 1 |
| Kay, HR | 1 |
| Hofman, A | 1 |
| Kruyssen, DA | 2 |
| Storm, CJ | 2 |
| Franklyn, JA | 1 |
| Davis, JR | 1 |
| Gammage, MD | 1 |
| Littler, WA | 1 |
| Ramsden, DB | 1 |
| Sheppard, MC | 1 |
| Müller-Brand, J | 1 |
| Kiowski, W | 1 |
| Zaza, A | 1 |
| Zuanetti, G | 1 |
| Mizon, JP | 1 |
| Rosa, A | 1 |
| Betermiez, P | 1 |
| Sevestre, H | 1 |
| Komajda, M | 1 |
| Farges, D | 1 |
| Michat, L | 1 |
| Frank, R | 1 |
| Fontaine, G | 1 |
| Grosgogeat, Y | 1 |
| Vergara, G | 1 |
| Disertori, M | 1 |
| Inama, G | 1 |
| Guarnerio, M | 1 |
| Bettini, R | 1 |
| Stirpe, E | 1 |
| Furlanello, F | 1 |
| Flaker, GC | 1 |
| Alpert, MA | 1 |
| Webel, RR | 1 |
| Ruder, MA | 1 |
| Sanfelippo, JF | 1 |
| Tsutakawa, RK | 1 |
| Brami, JL | 1 |
| Schlaeffer, F | 1 |
| Sobel, R | 1 |
| Pesola, A | 1 |
| Cosentino, G | 1 |
| Vercillo, C | 1 |
| De Vuono, T | 1 |
| Ibragin, MD | 1 |
| Bobrovskaia, TA | 1 |
| Kushlinskiĭ, NE | 1 |
| Olmos, L | 1 |
| Laugier, P | 1 |
| Antonelli, G | 2 |
| Brindicci, G | 2 |
| Calabrese, P | 1 |
| Franchini, G | 1 |
| Biasco, G | 1 |
| Miccoli, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00000531] | Phase 3 | 0 participants | Interventional | 1992-09-30 | Completed | ||
| Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias[NCT03413150] | 80 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for amiodarone and Coronary Disease
| Article | Year |
|---|---|
Mechanisms in endocrinology: Heart failure and thyroid dysfunction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Disease; | 2012 |
[Drug therapy of ventricular arrhythmias - a contemporary perspective].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials | 2002 |
[New generation of antiarrhythmic drug].
Topics: Amiodarone; Anti-Arrhythmia Agents; Bepridil; Coronary Disease; Humans; Randomized Controlled Trials | 1994 |
Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease?
Topics: Amiodarone; Clinical Trials as Topic; Coronary Disease; Death, Sudden, Cardiac; Defibrillators, Impl | 2005 |
[Current diagnostic and treatment problems in stenocardia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Angioplasty, Bal | 1982 |
Amiodarone and post-MI patients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Death, Sudden, Cardiac; | 1993 |
Amiodarone as a first-line drug in the treatment of atrial fibrillation: the protagonist viewpoint.
Topics: Amiodarone; Coronary Disease; Death, Sudden; Follow-Up Studies; Heart Failure; Humans; Sodium Channe | 1994 |
Empiric use of amiodarone and sotalol.
Topics: Amiodarone; Cardiomyopathy, Hypertrophic; Coronary Disease; Death, Sudden, Cardiac; Heart Diseases; | 1993 |
[Medical therapy of chronic coronary insufficiency].
Topics: Amiodarone; Angina Pectoris; Chronic Disease; Coronary Disease; Digitalis Glycosides; Humans; Lidofl | 1978 |
[Current aspects in the treatment of coronary ischemia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; C | 1991 |
Mechanisms and prevention of sudden death in coronary heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden; Humans | 1989 |
21 trials available for amiodarone and Coronary Disease
| Article | Year |
|---|---|
Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Blood Pressure Determination; Cardiac Output; Coronary A | 2003 |
Amiodarone for postoperative atrial fibrillation.
Topics: Amiodarone; Atrial Fibrillation; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationshi | 2004 |
Lower observed versus expected (based on U.S. age and gender specific rates) survival in patients treated for near-fatal ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Output; Case-Control Studies; Cohort Studies; Conf | 2004 |
Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Aged; Amiodarone; Analysis of Variance; Atrial Fibrilla | 2007 |
Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III).
Topics: Adipose Tissue; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Connecticut; Coronary | 2008 |
Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fib | 2008 |
Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Atrioventricular Node; Benzofurans; Clinical Trials a | 1983 |
[Experience with the clinical study of cordaron].
Topics: Adult; Aged; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Benzofurans; Clinical Trials as To | 1980 |
Amiodarone versus quinidine in the prophylaxis of atrial fibrillation.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Clinical Trials as Topic; Coronary Disease; Fem | 1981 |
Amiodarone as a first-line drug in the treatment of atrial fibrillation: the protagonist viewpoint.
Topics: Amiodarone; Coronary Disease; Death, Sudden; Follow-Up Studies; Heart Failure; Humans; Sodium Channe | 1994 |
Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Disease; Dos | 1995 |
Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Angiography; Coronary Disease; Dose-Response Relationsh | 1997 |
Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Confounding Factors, Epidemiologic; Coronary Disease; Deat | 1997 |
Effects of amiodarone on the P-wave triggered signal-averaged electrocardiogram in patients with paroxysmal atrial fibrillation and coronary artery disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Electrocardiography | 1999 |
Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Cross-Over Studies; Electrocardiography; | 1999 |
Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypas | 2001 |
Amiodarone versus a beta-blocker to prevent atrial fibrillation after cardiovascular surgery.
Topics: Aged; Amiodarone; Atrial Fibrillation; Coronary Artery Bypass; Coronary Disease; Heart Valves; Human | 2001 |
[Cordaron and nonachlasine in treatment of chronic coronary insufficiency].
Topics: Adrenergic beta-Agonists; Amiodarone; Benzofurans; Chronic Disease; Clinical Trials as Topic; Corona | 1975 |
Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Death, Sudden; Differential Thres | 1992 |
Antiarrhythmic drugs in advanced organic heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Dise | 1986 |
Effect of short and long term administration of amiodarone on ischaemia-induced left ventricular dysfunction. Implications for combined antianginal drug therapy.
Topics: Adult; Amiodarone; Angina Pectoris; Benzofurans; Coronary Disease; Female; Hemodynamics; Humans; Mal | 1985 |
158 other studies available for amiodarone and Coronary Disease
| Article | Year |
|---|---|
Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; | 2014 |
Dronedarone: an alternate choice to sotalol and amiodarone in the treatment of atrial fibrillation/flutter in patients who have coronary heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Dronedarone; Heart Conduc | 2014 |
[Paroxysmal atrial fibrillation well controlled. Why the sudden patient syncope?].
Topics: Amiodarone; Atrial Fibrillation; Clopidogrel; Coronary Disease; Diagnosis, Differential; Drug Therap | 2015 |
Invited commentary.
Topics: Age Factors; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fi | 2009 |
[Cardiac symptoms in endocrinologic disorders. Heart illness caused by the thyroid gland].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Atrial Fi | 2009 |
[Efficacy of transesophageal pacing for correction of newly diagnosed atrial fibrillation of type I in patients with coronary heart disease].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Co | 2009 |
[79-year-old patient with dyspnoea and blue skin colour].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Cyanosis; Dermatitis, Photoallergic; Dia | 2011 |
Arrhythmogenic right ventricular dysplasia presenting as acute coronary syndrome: a case report.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Coron | 2004 |
[Establishment of a novel arrhythmia model in rats].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Disease Models, | 2005 |
Pro-arrhythmic effects of amiodarone and concomitant rate-control medication.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Arrhythmia | 2006 |
[Recurrent hemoptysis following thienopyridines and amiodarone administration. therapeutic dilemma].
Topics: Aged; Amiodarone; Cardiovascular Agents; Clopidogrel; Coronary Disease; Drug Interactions; Drug Ther | 2005 |
[Amiodaron effects on atrioventricular conduction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bundle of His; Coronary Disease; Dose-Resp | 2006 |
[Drug therapy of unstable angina].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Calcium; Coronar | 1981 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhyth | 1982 |
[Anti-arrhythmic effectiveness of ethmozine, cordaron and rhythmodan in treating ischemic heart disease].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Cardiac Complexes | 1981 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Comp | 1983 |
[Detection and long-term treatment of ventricular extrasystole in patients with ischemic heart disease].
Topics: Adult; Amiodarone; Cardiac Complexes, Premature; Coronary Disease; Female; Heart Ventricles; Humans; | 1983 |
[Intravenous administration of cordaron in the emergency therapy of ventricular extrasystole in patients with ischemic heart disease].
Topics: Adult; Aged; Amiodarone; Benzofurans; Cardiac Complexes, Premature; Coronary Disease; Emergencies; F | 1983 |
[Interstitial pneumonitis and amiodarone].
Topics: Aged; Amiodarone; Benzofurans; Coronary Disease; Humans; Male; Middle Aged; Prednisone; Pulmonary Fi | 1984 |
Chronic administration of amiodarone and thyroid function: a follow-up study.
Topics: Adult; Aged; Amiodarone; Benzofurans; Chronic Disease; Coronary Disease; Female; Follow-Up Studies; | 1984 |
[Morphological criteria of the effectiveness of using kordaron and obzidan in experimental myocardial ischemia].
Topics: Amiodarone; Animals; Benzofurans; Coronary Disease; Dogs; Drug Evaluation, Preclinical; Histocytoche | 1984 |
[Effect of hand cooling test on arterial blood pressure and electrocardiographic changes in patients with coronary disease before and after administration of cordarone].
Topics: Adult; Amiodarone; Blood Pressure; Cold Temperature; Coronary Disease; Electrocardiography; Hand; He | 1984 |
Diffuse interstitial pulmonary disease during amiodarone treatment.
Topics: Amiodarone; Benzofurans; Coronary Disease; Humans; Lung; Lung Diseases; Male; Middle Aged | 1984 |
Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration.
Topics: Amiodarone; Animals; Benzofurans; Consciousness; Coronary Disease; Death, Sudden; Dogs; Electrocardi | 1983 |
[Effect of visken and cordarone on myocardial function in patients with ischemic heart disease].
Topics: Adult; Amiodarone; Benzofurans; Coronary Disease; Drug Therapy, Combination; Female; Hemodynamics; H | 1983 |
[Interactions between digoxin and amiodarone (Cordarone), verapamil (Isoptin) and melsidomine (Corvatone)].
Topics: Adult; Amiodarone; Cardiotonic Agents; Coronary Disease; Digoxin; Drug Interactions; Humans; Male; M | 1983 |
Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Electrocardiography; E | 1984 |
Suppression of high-grade ventricular ectopic activity by antiarrhythmic drug treatment as a marker for survival in patients with chronic coronary artery disease.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Female; Hum | 1984 |
[Effect of amiodarone on ventricular systolic time intervals in patients with coronary disease].
Topics: Adult; Amiodarone; Benzofurans; Coronary Disease; Heart Ventricles; Humans; Male; Middle Aged; Myoca | 1984 |
Electrophysiologic mechanism of exercise-induced sustained ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Cardiomyopathies; Catecholamines; Coronary Disease; Electrophys | 1983 |
Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Female; Heart Failure; | 1982 |
Oral amiodarone in high-risk ventricular arrhythmias.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; | 1982 |
[Digoxin-quinidine and digoxin-amiodarone interactions. Effects on blood levels of the cardioactive glycoside].
Topics: Adult; Aged; Amiodarone; Benzofurans; Coronary Disease; Digoxin; Drug Interactions; Female; Heart Di | 1981 |
[Hemodynamic and cineangiocardiographic effects of amiodarone in ischemic heart disease].
Topics: Amiodarone; Benzofurans; Blood Pressure; Cineangiography; Coronary Disease; Depression, Chemical; Fe | 1981 |
Amiodarone.
Topics: Amiodarone; Benzofurans; Blood Pressure; Coronary Disease; Hemodynamics; Humans | 1980 |
Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
Topics: Amiodarone; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cohort Studies; Coronary Disea | 1994 |
Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease.
Topics: Actuarial Analysis; Amiodarone; Cardiac Complexes, Premature; Coronary Disease; Death, Sudden, Cardi | 1994 |
[Computerized tomography aspects of amiodarone poisoning].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Dose-Response Relationship, Drug; Female | 1995 |
Divergent effects of chronic amiodarone administration on systolic and diastolic function in patients with heart disease.
Topics: Aged; Amiodarone; Blood Pressure; Coronary Disease; Diastole; Heart Rate; Humans; Male; Middle Aged; | 1995 |
Amiodarone and torsade de pointes.
Topics: Amiodarone; Coronary Disease; Humans; Risk Factors; Torsades de Pointes | 1995 |
Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
Topics: Adult; Aged; Amiodarone; Coronary Disease; Electrocardiography; Female; Heart Conduction System; Hum | 1993 |
Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Coronary Disease; Drug Resistance; Female | 1993 |
[Ventricular fibrillation during stress test on a treadmill. Apropos of a case].
Topics: Amiodarone; Atrial Fibrillation; Coronary Artery Bypass; Coronary Disease; Electric Countershock; El | 1993 |
Abnormal QT intervals associated with negative T waves induced by antiarrhythmic drugs are rapidly reduced using magnesium sulfate as an antidote.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Electrocardiography; Female; Humans; Magnesium | 1993 |
['Cardiac ballet' with and without amiodarone].
Topics: Aged; Amiodarone; Cardiac Pacing, Artificial; Coronary Disease; Electrocardiography; Female; Humans; | 1993 |
[Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Dise | 1995 |
Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Digitalis; Dogs | 1995 |
Combined transesophageal left atrial pacing and antiarrhythmic therapy in the treatment of atrial flutter.
Topics: Ambulatory Care; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrial Fun | 1996 |
[Early pulmonary changes caused by amiodarone].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Dose-Response Relationship, Drug; Drug A | 1996 |
Implantable cardioverter defibrillators in patients with Chagas' disease: are they different from patients with coronary disease?
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Chagas Cardiomyopathy; | 1997 |
Clinical predictors of defibrillation energy requirements.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Coronary Disease; Defi | 1997 |
Clinical trials of implantable defibrillators.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Disease; | 1997 |
XIX congress of the European Society of Cardiology August 24-28, 1997, Stockholm, Sweden.
Topics: Amiodarone; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Anticoagulants; Arteriosclerosis | 1997 |
[Pharmacologic treatment for ventricular arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Coronary Disease; Heart Failure; Humans; Recur | 1997 |
Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiac Catheterization; Cardiac | 1999 |
Temporal and geographical trends in indications for implantation of cardiac defibrillators in Europe 1993-1998. Medtronic ICD System Investigators.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Coronary Disease; Death, Sudden, Cardiac; Defi | 2000 |
Amiodarone to prevent recurrence of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Humans; Hypertrophy, Left | 2000 |
Effect of amiodarone +/- diltiazem +/- beta blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Atrial Fibrillation; Coronary Artery Bypass; Coronary | 2002 |
Pseudocyanotic pigmentation of the skin induced by amiodarone: a light and electron microscopic study.
Topics: Amiodarone; Benzofurans; Biopsy; Collagen; Coronary Disease; Cytoplasmic Granules; Female; Histiocyt | 1975 |
[Prinzmetal's angina initiated by interruption of exercise. 5 cases with normal coronary radiograms].
Topics: Adult; Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Atropine; Coronary Angiography; Corona | 1979 |
Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart.
Topics: Amiodarone; Animals; Benzofurans; Coronary Disease; Coronary Vessels; Cyclic AMP; Depression, Chemic | 1979 |
[Non-coronary effects of coronary agents].
Topics: Amiodarone; Blood Circulation; Central Nervous System; Cerebrovascular Circulation; Chromonar; Coron | 1977 |
Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease.
Topics: Adult; Amiodarone; Benzofurans; Cardiac Output; Coronary Disease; Coronary Vessels; Electrocardiogra | 1979 |
Effect of cordaron on the ischaemic myocardium and its blood vessels. An experimental study.
Topics: Amiodarone; Animals; Benzofurans; Blood Vessels; Connective Tissue; Coronary Circulation; Coronary D | 1979 |
Amiodarone.
Topics: Amiodarone; Benzofurans; Coronary Disease; Hemodynamics; Humans | 1979 |
[Use of amiodarone in the treatment of coronary deficiency. Result of clinical studies (author's transl)].
Topics: Amiodarone; Angina Pectoris; Benzofurans; Coronary Disease; Humans | 1979 |
[Amiodarone in the treatment of patients with ischemic heart disease].
Topics: Amiodarone; Benzofurans; Coronary Disease; Female; Humans; Male; Middle Aged | 1978 |
[Amiodarone and thyroid function].
Topics: Amiodarone; Benzofurans; Coronary Disease; Thyroid Diseases | 1976 |
[Hemodynamic effects of intravenous injections of amiodarone chlorhydrate in normal subjects and coronary patients].
Topics: Adult; Amiodarone; Benzofurans; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disea | 1976 |
[Hyperthyroidism due to amiodarone (author's transl)].
Topics: Amiodarone; Benzofurans; Coronary Disease; Heart Conduction System; Humans; Hyperthyroidism | 1976 |
[Value of cordaron effect - a new coronaroactive agent].
Topics: Adult; Aged; Amiodarone; Benzofurans; Coronary Disease; Female; Humans; Male; Middle Aged | 1976 |
[Clinical and experimental results of treatment with amiodarone in coronary insufficiency].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Dipyridamole | 1975 |
[Amiodarone, an anti-arrhythmic agent (apropos of a case of ventricular recurrent tachycardia in a coronary patient)].
Topics: Amiodarone; Benzofurans; Coronary Disease; Electrocardiography; Heart Ventricles; Humans; Male; Midd | 1975 |
Effects of amiodarone on thyroid function in patients with ischaemic heart disease.
Topics: Amiodarone; Angina Pectoris; Benzofurans; Blood Pressure; Cholesterol; Coronary Disease; Heart Rate; | 1975 |
[Electrophysiological bases of the antiarrhythmic activity of amiodarone (author's transl)].
Topics: Adult; Aged; Amiodarone; Benzofurans; Bundle of His; Coronary Disease; Electrophysiology; Female; He | 1975 |
Hepatotoxicity of amiodarone.
Topics: Aged; Amiodarone; Biopsy; Chemical and Drug Induced Liver Injury; Coronary Disease; Follow-Up Studie | 1992 |
Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.
Topics: Amiodarone; Cardiac Pacing, Artificial; Coronary Disease; Electrocardiography; Female; Heart Conduct | 1992 |
Effects of quinidine and amiodarone on blood pressure during rapid ventricular pacing in coronary artery disease.
Topics: Aged; Amiodarone; Analysis of Variance; Blood Pressure; Cardiac Pacing, Artificial; Coronary Disease | 1992 |
[Bilateral optic neuropathy following amiodarone therapy].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Fluorescein Angiography; Humans | 1992 |
Pulmonary complications after long term amiodarone treatment.
Topics: Amiodarone; Blood Gas Analysis; Coronary Disease; Cross-Sectional Studies; Exercise Test; Humans; Lu | 1992 |
Effect of amiodarone therapy on the time course of myocardial phospholipid hydrolysis during in vitro total ischaemia in cat hearts.
Topics: Amiodarone; Animals; Biopsy; Cats; Coronary Disease; Fatty Acids, Nonesterified; Hydrolysis; In Vitr | 1992 |
Amiodarone, adrenoceptor responsiveness and ischaemia- and reperfusion-induced arrhythmias.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Coronary Disease; In Vitro Techniques; Male; Myocardial C | 1991 |
Amiodarone pretreatment effects on ischemic isovolumic rat hearts: a P-31 nuclear magnetic resonance study of intracellular pH and high-energy phosphates contents evolutions.
Topics: Adenosine Triphosphate; Amiodarone; Animals; Blood Pressure; Coronary Circulation; Coronary Disease; | 1990 |
[Effect of amiodarone on signal-averaged and long-term ECG].
Topics: Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cardi | 1991 |
Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Cardiomyopathies; Coronary Disease; Death, Sudden, Cardi | 1991 |
[A method of choosing maintenance anti-arrhythmia therapy after sinus rhythm restoration in patients with a permanent form of atrial fibrillation].
Topics: Amiodarone; Atrial Fibrillation; Coronary Disease; Electric Countershock; Heart Rate; Humans; Method | 1991 |
Long-term amiodarone therapy raises serum cholesterol.
Topics: Adult; Aged; Amiodarone; Cholesterol; Coronary Disease; Female; Humans; Male; Middle Aged; Thyroid H | 1991 |
Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function.
Topics: Adult; Aged; Amiodarone; Coronary Disease; Female; Hemodynamics; Humans; Infusions, Intravenous; Mal | 1991 |
[Effect of amiodarone and disopyramide on the results of electrocardiographic exercise stress testing in patients with coronary disease].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Electrocardiography; Exercise Test | 1990 |
Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation.
Topics: Adolescent; Adult; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; | 1990 |
Selective depression of maximum rate of depolarization of guinea-pig ventricular action potentials by amiodarone and lignocaine in simulated ischaemia: comparison with encainide.
Topics: Action Potentials; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Coronary Disease; Encainid | 1990 |
Myocardial amiodarone and desethylamiodarone concentrations in patients undergoing cardiac transplantation.
Topics: Amiodarone; Chromatography, High Pressure Liquid; Coronary Disease; Heart Transplantation; Humans; M | 1990 |
Amiodarone--efficacy and late potentials during long-term therapy.
Topics: Amiodarone; Cardiomyopathy, Dilated; Coronary Disease; Electrocardiography; Humans; Prospective Stud | 1990 |
Effects of antiarrhythmic agents classified as class III group on ischaemia-induced myocardial damage in canine hearts.
Topics: Acetylglucosaminidase; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Blood Pressure; Coro | 1990 |
[Acute myocardial uptake of lidocaine, mexiletine and amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Catheterization; Coronary Disease; Humans; Injections, I | 1990 |
Interventional treatment for ventricular arrhythmias: the initial South Carolina case.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Drug Administration Schedule; Electric Cou | 1990 |
Cycle-length response of ventricular tachycardia associated with coronary artery disease to procainamide and amiodarone.
Topics: Amiodarone; Cardiac Pacing, Artificial; Coronary Disease; Electrophysiology; Female; Heart; Humans; | 1990 |
Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
Topics: Amiodarone; Atrial Fibrillation; Benzofurans; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; | 1986 |
Stability of electrophysiological parameters after acute amiodarone loading: implications for patient management.
Topics: Aged; Amiodarone; Analysis of Variance; Coronary Disease; Dose-Response Relationship, Drug; Electrop | 1989 |
Anti-arrhythmic effects of amiodarone and desethylamiodarone on malignant ventricular arrhythmias arising as a consequence of ischaemia and reperfusion in the anaesthetised rat.
Topics: Amiodarone; Anesthesia, Intravenous; Animals; Arrhythmias, Cardiac; Coronary Disease; Heart Ventricl | 1989 |
Differential electrophysiological effects of amiodarone on ventricular muscle and Purkinje fibers in canine one-day-old myocardial infarction.
Topics: Action Potentials; Amiodarone; Animals; Coronary Disease; Dogs; Electric Stimulation; Electrophysiol | 1989 |
Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Coronary Disease; Electric Stimulation; Electrocardiogra | 1989 |
[Amiodarone prophylaxis of ventricular tachycardia in ischemic cardiopathy].
Topics: Aged; Aged, 80 and over; Amiodarone; Coronary Disease; Death, Sudden; Electrocardiography; Female; H | 1989 |
Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease.
Topics: Amiodarone; Coronary Disease; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middl | 1989 |
The pharmacologic management of coronary artery disease in 1986.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Calcium Channel Blockers; Coronary Disease | 1986 |
[Experience with 5 years of drug therapy of ischemic heart disease patients with stable angina and stenosing atherosclerosis of the coronary arteries].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Angina Pectoris; Calcium Channel Blockers; Cardiac G | 1987 |
Our experience with amiodarone administration to patients with paroxysmal atrial fibrillation.
Topics: Amiodarone; Atrial Fibrillation; Coronary Disease; Female; Humans; Male; Middle Aged | 1988 |
Cellular electrophysiology of amiodarone in cardiac ischaemia.
Topics: Action Potentials; Amiodarone; Animals; Benzofurans; Coronary Disease; Electrophysiology; Heart; Rab | 1986 |
[Torsade de pointes: clinical experience of 9 patients].
Topics: Adult; Aged; Amiodarone; Coronary Disease; Electrocardiography; Female; Humans; Hypokalemia; Isoprot | 1988 |
Effects of low doses of amiodarone on cardiac arrhythmias in patients with chronic ischaemic heart disease.
Topics: Aged; Amiodarone; Angiocardiography; Arrhythmias, Cardiac; Coronary Disease; Dose-Response Relations | 1988 |
[Clinico-pharmacological interactions of digoxin with ethmozine, disopyramide and amiodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Digoxin; Disopyramide; Drug Synergism; Drug Ther | 1988 |
Amiodarone-associated pulmonary fibrosis. Evidence of an immunologically mediated mechanism.
Topics: Amiodarone; Coronary Disease; Drug Therapy, Combination; Electrophoresis, Polyacrylamide Gel; Fluore | 1987 |
Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrop
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Disea | 1988 |
Use dependence of amiodarone during the sinus tachycardia of exercise in coronary artery disease.
Topics: Administration, Oral; Amiodarone; Coronary Disease; Dose-Response Relationship, Drug; Electrocardiog | 1988 |
Prognostic value of bicycle ergometry in medically treated patients with three-vessel coronary artery disease.
Topics: Adult; Amiodarone; Coronary Disease; Exercise Test; Humans; Male; Nitrates; Prognosis; Streptokinase | 1988 |
The effect of intravenous amiodarone on heart rate in patients with acute myocardial infarction or ischemia and sinus tachycardia.
Topics: Aged; Aged, 80 and over; Amiodarone; Coronary Disease; Female; Heart Rate; Humans; Infusions, Intrav | 1988 |
Elevation of serum total cholesterol and triglyceride levels during amiodarone therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cholesterol; Coronary Disease; Female; Humans; Longitudinal Studie | 1988 |
Prevention by amiodarone of phospholipid depletion in isoproterenol-induced ischemia in rats.
Topics: Amiodarone; Animals; Chlorpromazine; Cholesterol; Coronary Disease; Creatine Kinase; Isoproterenol; | 1987 |
Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Bronchoalveolar Lavage Fluid; Coronary Disease; Follo | 1987 |
Effect of amiodarone on coronary reperfusion-induced ventricular arrhythmias in dogs.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Dogs; Female; Mal | 1986 |
Comparison of survival of amiodarone-treated patients with coronary artery disease and malignant ventricular arrhythmias with that of a control group with coronary artery disease.
Topics: Aged; Amiodarone; Coronary Disease; Female; Heart Ventricles; Humans; Male; Middle Aged; Prognosis; | 1987 |
Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Dose-Response Relationship, Drug; Electroc | 1987 |
Protective effects of amiodarone pretreatment on mitochondrial function and high energy phosphates in ischaemic rat heart.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Amiodarone; Animals; Coronar | 1987 |
Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Disease; Female; Follow | 1987 |
The influence of ischaemia on the electrophysiological properties of amiodarone in chronically treated rabbit hearts.
Topics: Action Potentials; Administration, Oral; Amiodarone; Animals; Coronary Disease; Electrophysiology; F | 1987 |
Myocardial protective effect of amiodarone in hypertrophied hearts during global ischemia.
Topics: Amiodarone; Animals; Benzofurans; Cardiac Output; Coronary Disease; Dose-Response Relationship, Drug | 1986 |
Probable early acute hepatitis with parenteral amiodarone.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Biopsy; Chemical and Drug Induced Liver Injury; | 1986 |
An experimental approach to the choice of antiarrhythmic therapy.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Diltiazem | 1986 |
Effect of amiodarone on ventricular fibrillation and defibrillation thresholds in the canine heart under normal and ischemic conditions.
Topics: Amiodarone; Animals; Benzofurans; Coronary Disease; Dogs; Electric Countershock; Electric Stimulatio | 1986 |
Amiodarone as a cause of electrocardiographic changes simulating myocardial ischemia or subendocardial infarction.
Topics: Amiodarone; Coronary Disease; Diagnosis, Differential; Electrocardiography; Female; Heart; Humans; M | 1986 |
[Efficacy of amiodarone in chronic stable coronary insufficiency].
Topics: Adult; Aged; Amiodarone; Angina Pectoris; Chronic Disease; Coronary Disease; Exercise Test; Female; | 1986 |
Comparison of programmed stimulation and Holter monitoring for predicting long-term efficacy and inefficacy of amiodarone used alone or in combination with a class 1A antiarrhythmic agent in patients with ventricular tachyarrhythmia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; | 1987 |
[Drug therapy of coronary ischemia].
Topics: Amiodarone; Calcium Channel Blockers; Coronary Disease; Humans; Vasodilator Agents | 1985 |
Amiodarone. The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Carbimazole; Coronary Disease; Humans; Hyperthy | 1985 |
[Characteristics of patients with ischemic heart disease under dispensary observation in a regional polyclinic and the evaluation of anti-angina therapy conducted under dispensary conditions].
Topics: Adult; Ambulatory Care; Amiodarone; Angina Pectoris; Coronary Disease; Drug Therapy, Combination; Fo | 1985 |
Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Female; Hu | 1985 |
Syncope, tachycardia, and exertional dyspnea.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Catheterization; Coronary Disease; Dyspnea; Elect | 1985 |
[Relation between therapeutic efficacy of antianginal preparations in patients with ischemic heart disease and their effect on the rheologic properties of blood].
Topics: Adult; Amiodarone; Benzofurans; Blood Coagulation; Blood Viscosity; Coronary Disease; Erythrocyte Ag | 1985 |
Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Di | 1986 |
Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity.
Topics: Aged; Amiodarone; Benzofurans; Coronary Disease; Death, Sudden; Drug Evaluation; Electrocardiography | 1986 |
Importance of modes of electrical termination of ventricular tachycardia for the selection of implantable antitachycardia devices.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Disease; Humans; Male; Middle | 1986 |
Amiodarone for refractory cardiac arrhythmias: 10-year study.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Coro | 1986 |
Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.
Topics: Adult; Aged; Amiodarone; Benzofurans; Coronary Disease; Electrophysiology; Female; Humans; Male; Mid | 1985 |
Acute hemodynamic and antiischemic effects of intravenous amiodarone.
Topics: Adult; Aged; Amiodarone; Benzofurans; Blood Pressure; Cardiac Pacing, Artificial; Coronary Disease; | 1985 |
Amiodarone and thyroid hormone action.
Topics: Adult; Aged; Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Cell Nucleus; Coronary Disease; | 1985 |
Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction.
Topics: Administration, Oral; Adult; Amiodarone; Angina Pectoris; Benzofurans; Blood Pressure; Coronary Dise | 1985 |
The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Disease M | 1985 |
Amiodarone. Haemodynamic profile during intravenous administration and effect on pacing-induced ischaemia in man.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Hemodynamics; Humans; Myoc | 1985 |
[Neuropathy and cerebellar syndrome induced by amiodarone].
Topics: Amiodarone; Benzofurans; Cerebellar Diseases; Coronary Disease; Diabetes Mellitus; Humans; Lipids; L | 1985 |
[Efficacy and side effects of long-term treatment with amiodarone. Retrospective study. Apropos of 460 cases].
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Coronary Disease; Fem | 1985 |
[Sustained ventricular tachycardia in postinfarct ischemic heart disease: spontaneous polymorphism. Clinical, therapeutic and prognostic aspects].
Topics: Adult; Aged; Amiodarone; Coronary Disease; Electrocardiography; Female; Heart Ventricles; Humans; Ma | 1985 |
Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Cardiomyopathies; Coronary Disease; Drug Resi | 1985 |
Amiodarone-induced dysthyroidism.
Topics: Amiodarone; Benzofurans; Coronary Disease; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle Age | 1985 |
Lung disease associated with amiodarone treatment.
Topics: Aged; Amiodarone; Benzofurans; Coronary Disease; Female; Humans; Pneumonia; Pulmonary Fibrosis; Radi | 1985 |
[Complications of treatment with cordarone].
Topics: Amiodarone; Benzofurans; Coronary Disease; Humans; Hyperthyroidism; Male; Middle Aged | 1985 |
[Skin pigmentation by amiodarone. Ultrastructural study].
Topics: Aged; Amiodarone; Benzofurans; Coronary Disease; Diagnosis, Differential; Female; Humans; Pigmentati | 1974 |
[Anti-arrhythmic activity of amiodarone in ischemic heart disease].
Topics: Amiodarone; Benzofurans; Coronary Disease; Humans; Middle Aged | 1973 |
[Hemodynamic changes induced by amiodarone in patients with ischemic heart disease].
Topics: Amiodarone; Benzofurans; Coronary Disease; Female; Hemodynamics; Humans; Male; Middle Aged | 1973 |